Patients receiving IV antibiotics at home have similar safety and quality metrics comparable to those of patients receiving inpatient care, with no meaningful differences in mortality, treatment failure or complications. Home-based care is also typically less expensive than hospital treatment because it avoids daily facility and bed costs. That matters for healthcare facilities and payors.
Many IV antibiotic patients remain in hospitals even when evidence shows they can safely continue treatment at home with RN-led care and clinical oversight. Shifting to home IV antibiotic therapy reduces avoidable inpatient days, opens bed capacity and lowers the total cost of care.
BrightStar Care® partners with organizations to support safe, coordinated home IV antibiotic programs that ease pressure on inpatient systems.
The Cost of Inpatient Antibiotic Treatment
Length-of-Stay Burden on Health Systems
Bed utilization, throughput impact and facility cost per day
Inpatient IV antibiotic therapy often requires extended stays for conditions such as osteomyelitis, endocarditis and complex infections. These days add significant pressure to hospital capacity.
Each inpatient day carries high fixed and variable costs, including staffing, room/bed use, pharmacy services and monitoring. When beds are occupied by clinically stable patients, hospitals lose throughput capacity for higher-acuity admissions and surgical cases.
Financial Risk for Payors
Extended inpatient IV antibiotic therapy increases costs for payors, especially when patients are stable enough to leave the hospital. Each extra hospital day adds avoidable cost and may increase exposure to readmission penalties tied to unnecessary utilization.
Research shows that outpatient antimicrobial therapy costs much less than inpatient care. A population-based study found average costs of about $30,166 for outpatient treatment compared to $50,038 for inpatient care. That’s more than $17,000 in savings per episode.
At the same time, outpatient care shows similar overall safety and no significant difference in adverse events. For payors, this creates a clear way to lower total cost of care while maintaining clinical oversight through RN-led home-based programs.
How Home IV Antibiotic Therapy Works
Eligible Conditions and Patient Criteria
Home IV antibiotic therapy is used for patients who need IV treatment but are stable enough to leave the hospital.
Common conditions include:
- Osteomyelitis
- Endocarditis in stable phases
- Complicated urinary tract infections (UTIs)
- Skin and soft tissue infections that require IV therapy
- Post-acute or post-surgical infection care
Care teams decide if a patient is a good fit for home treatment. This usually includes hospital teams, infectious disease physicians and discharge planners.
They look at several factors, including:
- Patient stability
- Home environment
- Caregiver support
- Ability to follow the treatment plan
The goal is to treat each patient in the right setting based on their needs, not to replace hospital care when it is still required.
RN-Led Administration and Monitoring at Home
BrightStar Care delivers home IV antibiotic therapy through RN-led care teams trained in infusion administration, vascular access and clinical monitoring.
Care includes:
- IV antibiotic administration in the home
- Central line and peripheral IV care
- Ongoing patient assessment and monitoring
- Early identification of adverse reactions or complications
- Coordination with prescribing providers and care teams
- Patient and caregiver education to support safe care at home
This approach extends clinical oversight beyond the hospital while keeping clear communication and accountability in place.
Outpatient parenteral antimicrobial therapy programs show similar safety and outcomes to inpatient care when strong protocols and monitoring are used.
Site-of-Care Shift and Length-of-Stay Reduction
Clinically Equivalent Outcomes at Lower Cost
More healthcare systems are moving IV antibiotic care out of the hospital and into the home when it is safe to do so. This shift helps match patients to the right setting for their care.
Research shows outpatient parenteral antimicrobial therapy delivers similar results to inpatient care when patients are carefully selected. Rates of treatment success, complications and adverse reactions are comparable.
Shorter hospital stays can also reduce the risk of hospital-acquired infections. For the right patients, IV antibiotic therapy can safely continue at home with RN-led care and clinical oversight. This approach supports strong quality metrics while lowering the total cost of care.
Faster Discharge Pathways and Bed Recovery
Integrating home IV antibiotic therapy into discharge planning helps healthcare facilities improve patient flow and reduce avoidable hospital days.
Key benefits include:
- Earlier discharge once patients are stable
- More beds available for higher-acuity patients
- Less emergency department crowding
- Better scheduling for surgeries and procedures
Even small reductions in length of stay can make a big difference in patient throughput and overall capacity. Home IV antibiotic therapy allows patients to safely finish treatment at home with an RN instead of staying in acute care beds.
ROI for Payors and Health Systems
Cost Savings Per Episode of Care
Home IV antibiotic therapy costs less per episode than inpatient care. Studies show meaningful savings when patients are safely treated outside the hospital. One analysis found outpatient IV therapy costs about 5.5 times less than inpatient care.
These savings come mainly from shorter hospital stays and lower use of hospital beds and resources.
- For payors, this means lower total cost of care and fewer dollars spent on avoidable hospital days.
- For healthcare facilities, it means more beds available for higher-acuity patients and better use of staff and resources.
Across large patient populations, these savings can scale quickly and support stronger financial performance.
Reduced Readmissions and Penalty Risk
Safety and quality are key to moving IV antibiotic therapy into the home. When patients are carefully selected and supported by RN-led monitoring, home-based IV therapy can deliver outcomes that are comparable to inpatient care. At the same time, patients avoid the risks that come with longer hospital stays, including hospital-related infections.
For payors and health systems, this creates meaningful long-term value beyond the cost of a single episode of care:
- Lower risk of avoidable readmissions
- Reduced exposure to penalties tied to readmissions and hospital-acquired complications
- Stronger performance in value-based care contracts that reward quality and outcomes
When appropriate, patients receive IV antibiotics at home with RN oversight, care can remain safe while the system avoids unnecessary inpatient utilization.
BrightStar Care’s Home IV Antibiotic Program
Rapid Deployment and Care Coordination
BrightStar Care helps hospitals and payors by moving patients from hospital IV antibiotics to care at home as soon as they are ready.
This requires coordination across several teams, including:
- Hospital discharge planners
- Case management teams
- Utilization management teams
- Specialty pharmacy partners
- Referring physicians
When coordination is delayed, patients may stay in the hospital longer than needed, even if they are clinically ready to leave. BrightStar Care helps close that gap with clear communication and rapid deployment of RN-led care teams.
The result is a smoother transition from hospital to home and fewer avoidable inpatient days.
Scalable, Nationwide Infusion Nursing
With more than 400 locations across 41 states, BrightStar Care provides national reach and local clinical oversight. This helps ensure consistent RN-led infusion care in different regions.
This model allows organizations to scale care without building new infrastructure in every market.
Key strengths include:
- Standard clinical processes across locations
- RN-led supervision and consistent staff training
- Flexible capacity to handle changes in patient volume
- Smooth coordination with partner care teams
BrightStar Care works as an extension of your care team, helping patients move safely between care settings while improving efficiency.
Lower Overall Costs With Home-Based IV Antibiotic Care
Home IV antibiotic therapy offers a clinically supported, cost-effective alternative to extended inpatient care for appropriate patients.
For healthcare facilities and payors, the opportunity is clear. Reduce avoidable inpatient days, improve throughput and lower total cost of care while maintaining RN-led clinical oversight.
BrightStar Care partners with organizations to support this site-of-care shift through structured, scalable home infusion programs designed for safety, coordination and operational efficiency. Learn more about our business partnerships.